Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
65.00
-2.07 (-3.09%)
At close: May 16, 2025, 4:00 PM
64.40
-0.60 (-0.92%)
After-hours: May 16, 2025, 4:05 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $2.08 billion as of May 16, 2025. Its market cap has increased by 75.67% in one year.
Market Cap
2.08B
Enterprise Value
1.93B
1-Year Change
75.67%
Ranking
Category
Stock Price
$65.00
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $2.08B, an increase of 1,338.00%. That is a compound annual growth rate of 139.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2025 | 2.17B | 11.12% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.79B |
| Johnson & Johnson | 358.72B |
| AbbVie | 314.05B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 238.07B |
| Abbott Laboratories | 229.85B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |